Dec 07, 2015

News from SWOG: Triple Drug Combination Beats Standard Treatment in Myeloma Trial

A SWOG trial shows bortezomib, lenalidomide, and dexamethasone delays recurrence and lengthens life for myeloma patients, indicating a possible new standard of care. SWOG is a publicly funded worldwide network of researchers who design and conduct cancer clinical trials. The Group’s goal is to change medical practice so it improves the lives of people with […]

Read More →